✦ LIBER ✦

A placebo-controlled study of three agomelatine dose regimens (10mg, 25mg, 25–50mg) in patients with major depressive disorder

✍ Scribed by Kennedy, Sidney H.; Avedisova, Alla; Giménez-Montesinos, Natalia; Belaïdi, Carole; Christian de, Bodinat

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2249 – Efficacy and safety of 3 agomelat

✍ Kennedy, S.H.; Avedisova, A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 41 KB

P.2.057 Confirmed clinical efficacy of a

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Comparable efficacy and safety of 8 week

✍ Shu, L.; Sulaiman, A.H.; Huang, Y.S.; Fones Soon Leng, C.; Crutel, V. Strijckman 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 378 KB

EPA-0396 – Sustained efficacy and safety

✍ Kennedy, S.H.; Avedisova, A.; Picarel, F.; De Bodinat, C. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 72 KB

A double-blind, randomized, placebo-cont

✍ Michael R Liebowitz, Karen A Tourian, Eunhee Hwang, Linda Mele 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 214 KB

A randomized, double-blind, 24‐week stud

✍ Colonna, Lucien; Andersen, Henning Friis; Reines, Elin Heldbo 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 358 KB